drugset / Trial / NCT06476509

A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET

NCT06476509

Phase 1 Completed 20 enrolled Vigonvita Life Sciences
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study was a non-randomized, open-label clinical study to assess Serotonin transporter occupancy in the brain of healthy adults using 11C-DASB positron emission tomography (PET)

Timeline

Start
2024-05-30
Primary completion
2025-01-19
Completion
2025-05-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Escitalopram Small molecule 20 mg Oral
Subject LV232 Unknown 20 mg Oral
Subject LV232 Unknown 40 mg Oral
Subject LV232 Unknown 60 mg Oral